SE8303700D0 - Terapeutisk komposition - Google Patents

Terapeutisk komposition

Info

Publication number
SE8303700D0
SE8303700D0 SE8303700A SE8303700A SE8303700D0 SE 8303700 D0 SE8303700 D0 SE 8303700D0 SE 8303700 A SE8303700 A SE 8303700A SE 8303700 A SE8303700 A SE 8303700A SE 8303700 D0 SE8303700 D0 SE 8303700D0
Authority
SE
Sweden
Prior art keywords
therapeutic composition
hydroxydecanoic acid
decalactone
lactone
delta
Prior art date
Application number
SE8303700A
Other languages
English (en)
Other versions
SE462419B (sv
SE8303700L (sv
Inventor
H Ohnishi
K Yamaguch
Y Suzuki
N Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8303700D0 publication Critical patent/SE8303700D0/sv
Publication of SE8303700L publication Critical patent/SE8303700L/sv
Publication of SE462419B publication Critical patent/SE462419B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D315/00—Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8303700A 1982-06-28 1983-06-28 Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar SE462419B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57111183A JPS591415A (ja) 1982-06-28 1982-06-28 循環系疾患治療剤

Publications (3)

Publication Number Publication Date
SE8303700D0 true SE8303700D0 (sv) 1983-06-28
SE8303700L SE8303700L (sv) 1983-12-29
SE462419B SE462419B (sv) 1990-06-25

Family

ID=14554592

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303700A SE462419B (sv) 1982-06-28 1983-06-28 Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar

Country Status (11)

Country Link
US (1) US4578400A (sv)
JP (1) JPS591415A (sv)
AU (1) AU546935B2 (sv)
CA (1) CA1209921A (sv)
CH (1) CH660556A5 (sv)
DE (1) DE3323264C2 (sv)
FR (1) FR2529081B1 (sv)
GB (1) GB2123691B (sv)
IT (1) IT1173725B (sv)
NL (1) NL187299C (sv)
SE (1) SE462419B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2665737B2 (ja) * 1986-05-27 1997-10-22 宇部興産株式会社 微粒子状無機フイラー分散液の製造法
CA2016467A1 (en) 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US8334135B2 (en) * 2002-07-31 2012-12-18 Yves Saint Laurent Parfums Stem cells from adipose tissue, and differentiated cells from said cells
ATE482698T1 (de) * 2003-06-18 2010-10-15 Inst Cardiologie De Montreal M Vermeidung von vorhofflimmern (af) mit der verwendung von statin
DE102004052697A1 (de) * 2004-10-29 2006-05-04 Haehner, Thomas, Dr. Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation
US8722734B2 (en) * 2005-03-02 2014-05-13 Merck Sharp & Dohme Corp. Composition for inhibition of cathepsin K
DE102006019906A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptable Salze zur Herstellung einer pharmazeutischen Zubereitung
JP5469781B1 (ja) * 2012-03-27 2014-04-16 辻本化学工業株式会社 ＰＰＡＲｓアゴニスト活性亢進薬
JP7193471B2 (ja) * 2017-04-10 2022-12-20 ヴィタフロ （インターナショナル） リミテッド てんかんの治療に使用するための組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1417119A (en) * 1972-11-30 1975-12-10 Thiele G H Process for treating bones
US4225501A (en) * 1977-07-25 1980-09-30 Givaudan Corporation 1,4-Epoxy-1,3,3-trimethyl-2-(2-buten-1-ylidene)-cyclohexanes
US4357315A (en) * 1980-08-07 1982-11-02 International Flavors & Fragrances Inc. Use of 1-ethoxy-1-ethanol acetate for augmenting or enhancing the taste of toothpaste

Also Published As

Publication number Publication date
CH660556A5 (de) 1987-05-15
FR2529081A1 (fr) 1983-12-30
IT8348588A0 (it) 1983-06-28
SE462419B (sv) 1990-06-25
DE3323264C2 (de) 1986-03-06
AU1631583A (en) 1984-01-05
GB2123691B (en) 1985-07-31
JPS591415A (ja) 1984-01-06
FR2529081B1 (fr) 1985-11-15
NL187299B (nl) 1991-03-18
GB8317357D0 (en) 1983-07-27
GB2123691A (en) 1984-02-08
US4578400A (en) 1986-03-25
DE3323264A1 (de) 1984-01-05
IT1173725B (it) 1987-06-24
AU546935B2 (en) 1985-09-26
JPH0142246B2 (sv) 1989-09-11
NL8302273A (nl) 1984-01-16
CA1209921A (en) 1986-08-19
SE8303700L (sv) 1983-12-29
NL187299C (nl) 1991-08-16

Similar Documents

Publication Publication Date Title
FI793238A (fi) Difenylbutyl-piperazinekarboxamider
JPS5564571A (en) Novel 1*44dihydropyridine compound having substituted ester group
DE3880047D1 (de) Zusammensetzung eines zusatzes.
BE848712A (fr) Compositions d'acides carboxyliques,
IT1083151B (it) Procedimento d'idrocianazione di composti organici insaturi comportanti almeno un doppio etilenico
IT1145377B (it) Procedimento per la polimerizzazione per irradiazione di composizioni di poliacrilati
JPS53135931A (en) Lysine ester triisocyanate
FR2533929B1 (fr) Ester methylique de l'acide 25, 26, 27 -trinor-1a, 2b-epoxy-cholesta-4,6-diene-3-one-24-oique
SE8303700L (sv) Terapeutisk komposition
BE890230A (fr) Compositions pharmaceutiques accelerant la guerison de blessures
DK164191C (da) Fungicid og fremgangsmaader til dets fremstilling og til dets anvendelse til bekaempelse af svampe
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1131856B (it) Composizione farmaceutica per il trattamento di intossicazioni alcooliche
JPS549240A (en) New derivative of phenylglycolic acid, its preparation and analgesic and antiinflammatory agent contining it as effective component
SE8206128L (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
BR8100870A (pt) Processo para a preparacao de esteres de trifluormetil-benzila, composicao praguicida, processo para o combate de pragas e para a apreparacao das composicoes praguicidas
IT7823886A0 (it) Composizione per il trattamento di malattie allergiche.
ATE5372T1 (de) Zusammensetzungen fuer die behandlung von krankheiten der kreislauforgane.
JPS53116374A (en) Cyclic phosphoric acid amide esters, process for their preparation and insecticides containing the same
IT8322692A0 (it) Composizioni per il trattamento della ruggine.
DK374281A (da) Fremgangsmaade til fremstilling af acylerede furanyl- og thienylacrylsyrer
JPS53127552A (en) Cellulose organic acid ester resin composition
JPS5422344A (en) Cycloprophanecarboxylic acid esters, insecticides containing the same as active agent, and their preparation
FI812774L (fi) Foerfarande foer framstaellning av n-4-/(2,4-diamino-6-pteridinyl)-metyl/metylamino/benzoyl/glutaminsyra
IT7848486A0 (it) Composizioni per il trattamento di infezioni da elminti

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8303700-2

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8303700-2

Format of ref document f/p: F